The Pancrelipase Tablets, cataloged under National Stock Number 6505-01-352-2389, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Schwarz Pharma, Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-352-2389 |
| Primary Part Number | NDC00091-3525-01 |
| Item Name | Pancrelipase Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Schwarz Pharma, Inc. |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 30000.000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 8000.000 USP UNITS LIPASE ACTIVE INGREDIENT AND 30000.000 USP UNITS PROTEASE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00091-3525-01 PRIMARY | Schwarz Pharma, Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00536-4395-01 | 5/9 Secondary reference Rugby Group Inc |
NSN 6505-01-352-2389 is a Pancrelipase Tablets, manufactured by Schwarz Pharma, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-352-2389 has 1 manufacturer part number on file: NDC00091-3525-01 (Schwarz Pharma, Inc.).
Key specifications for NDC00091-3525-01: Administration: ORAL; Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.